Therapeutic potential Nanoprobes is advancing drug delivery nanoparticles, radiation enhancing nanoparticles, and magnetic nanoparticles for hyperthermia to treat cancer, presenting opportunities to partner on co-development, grant-funded programs, and early-access clinical validation.

Imaging and contrast A broad portfolio of gold-based labeling reagents and in vivo micro-CT contrast agents positions Nanoprobes for sales to preclinical imaging labs, core facilities, and contract research organizations seeking enhanced imaging modalities.

Correlative tools FluoroNanogold and related CLEM probes offer synergies with established microscopy platforms, enabling customers to upgrade or expand their imaging workflows and attract researchers transitioning to correlative light and electron techniques.

SBIR STTR leverage Experience securing SBIR and STTR grants indicates potential for funded collaborations and joint development opportunities, appealing to government and academia-focused buyers seeking cost-shared innovation.

High niche demand Specialized reagents and conjugates such as Ni-NTA Nanogold, Och downstream functionalized nanoparticles, and ultrasensitive staining substrates target niche research needs, suggesting sales opportunities through specialty distributors and direct outreach to targeted biomedicine labs.